Methylprednisolone Powder
NDC Package 22552-0029-1
Package Information
Methylprednisolone powders is methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. This formulation utilizes a powder delivery system. Marketed by Symbiotec Pharmalab Limited, this product is identified by NDC 22552-0029.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 22552 - Symbiotec Pharmalab Limited
- 22552-0029 -
- 22552-0029-1 - 1 BAG in 1 CONTAINER / 25000 g in 1 BAG
- 22552-0029 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 22552-0029-1 identifies a specific commercial package of 1 bag in 1 container / 25000 g in 1 bag of Methylprednisolone (UNFINISHED drug), a bulk ingredient labeled by Symbiotec Pharmalab Limited. This powder is formulated for use and contains methylprednisolone as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Symbiotec Pharmalab Limited on August 24, 2011. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Methylprednisolone is used to treat conditions such as arthritis, blood disorders, severe allergic reactions, certain cancers, eye conditions, skin/kidney/intestinal/lung diseases, and immune system disorders. It decreases your immune system's response to various diseases to reduce symptoms such as swelling, pain, and allergic-type reactions. This medication is a corticosteroid hormone. Methylprednisolone may also be used with other medications in hormone disorders.
How is this Symbiotec Pharmalab Limited product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 22552002901. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.